Health committee  Your question is in relation to the mandate and the work of the Patented Medicine Prices Review Board. Unfortunately, I'm not in a position to comment on what information is made available to the board when making their price determinations. As you may know, Mr. Davies, they sit

Health committee  As I think I mentioned last time, the department published proposed regulations to modernize the PMPRB in the Canada Gazette, part I almost a year ago, in December 2017. The proposal hasn't been finalized. We continue to consider the results of that consultation and engage with s

Health committee  I can speak a bit in terms of price. As you're likely aware, the only federal lever that is able to exert any authority over price of patented medicines in Canada is the Patented Medicine Prices Review Board. I'm sure I answered a question related to the modernization effort fr

Health committee  The changes you're referring to are proposed amendments to the patented medicines regulations, which would modernize the way the Patented Medicine Prices Review Board looks at setting non-excessive prices for patented medicine. They were published in the Canada Gazette last Decem

Health committee  Thanks very much for the question. As Cathy was mentioning, ultimate access for many Canadians relies on a drug being reimbursed through either their public drug plan or a private plan. That's why the alignment with the health technology assessment is so important. As you're lik